A strategy for high-throughput analysis of levosimendan and its metabolites in human plasma samples using sequential negative and positive ionization liquid chromatography/tandem mass spectrometric detection

Rapid Communications in Mass Spectrometry

Volumn 21, Issue 14, 2007, Pages 2169-2176

  Zhang, Jun ^a   Gage, Eric M ^a   Ji, Qin C ^a   El Shourbagy, Tawakol A ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETONITRILE; BIOMOLECULES; CHEMICAL PROPERTIES; DRUG PRODUCTS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH PRESSURE LIQUID CHROMATOGRAPHY; IONIZATION; MASS SPECTROMETERS; MASS SPECTROMETRY; ORGANIC SOLVENTS; THROUGHPUT;

ACTIVE METABOLITES; AMMONIUM ACETATE; CLINICAL STUDY; HIGH-THROUGHPUT; HIGH-THROUGHPUT ANALYSIS; HUMAN PLASMA SAMPLES; IN-PHASE; IONIZATION MODES; SAMPLE VOLUME; TANDEM MASS SPECTROMETRIC DETECTION;

METABOLITES;

EID: 34547212315     PISSN: 09514198     EISSN: 10970231     Source Type: Journal    
DOI: 10.1002/rcm.3046     Document Type: Article

References (27)

1. Michaels AD, McKeown B, Kostal M, Vakharia KT, Jordan MV, Gerber IL, Foster E, Chatterjee K. Circulation 2005; 111: 1504.
2. Cleland JGF, Nikitin N, McGowan J. Expert Rev. Cardiovasc. Ther. 2004; 2: 9.
3. Innes CA, Wagstaff AJ. Drugs 2003; 63: 2651.
4. Li F, Zhang D, Lu X, Wang Y, Xiong Z. Biomed. Chromatogr. 2004; 18: 866.
5. Karlsson M, Korkolainen T, Wikberg T. Biomed. Chromatogr. 1995; 11: 54.
6. Stokvis E, Rosing H, Beijnen JH. Mass Spectrom. Rev. 2005; 24: 887.
7. Hopfgartner G, Bourgogne E. Mass Spectrom. Rev. 2003; 22: 195.
8. Zweigenbaum J, Heinig K, Steinborner S, Wachs T, Henion J. Anal. Chem. 1999; 71: 2294.
9. Steinborner S, Henion J. Anal. Chem. 1999; 71: 2340.
10. Jemal M, Teitz D, Ouyang Z, Khan S. J. Chromatogr. B 1999; 732: 501.
11. Zhang N, Hofman KL, Li W, Rossi DT. J. Pharm Biomed. 2000; 22: 131.
12. Zweigenbaum J, Henion J. Anal. Chem. 2000; 72: 2446.
13. Ramos L, Bakhtiar R, Tse FLS. Rapid Commun. Mass Spectrom. 2000; 14: 740.
14. Hoke SH II, Tomlinson JA II, Bolden RD, Morand KL, Pinkston JD, Wehmeyer KR. Anal. Chem. 2001; 73: 3083.
15. Shen Z, Wang S, Bakhtiar R. Rapid Commun. Mass Spectrom. 2002; 16: 332.
16. Bolden RD, Hoke SH II, Eichhold TH, McCauley-Myers DL, Wehmeyer KR. J. Chromatogr. B. 2002; 772: 1.
17. Shen A, Skriba HT, Mai H, Weiboldt RC, Chang MS, Ji QC, El-Shourbagy TA. Proc. 48th ASMS Conf. Mass Spectrometry and Allied Topics, Long Beach, CA, 2000; poster 296.
18. Zhou JY, Shen A, Ji QC, El-Shourbagy TA. Proc. 49th ASMS Conf. Mass Spectrometry and Allied Topics, Chicago, IL, 2001; poster 231.
19. Brignol N, McMahon LM, Luo S, Tse FLS. Rapid Commun. Mass Spectrom. 2001; 15: 898.
20. Ji QC, Reimer TM, El-Shourbagy TA. J. Chromatogr. B 2004; 805: 67.
21. Zhang J, Reimer MT, Ji QC, Watson P, Alexander NE, Flick J, Rodila R, Chang MS, El-Shourbagy TA, Burke S, Schwartz L. Anal. Bioanal. Chem. 2007; 387: 2745.
22. Wang P, Zhang J, Gage E, Schmidt JM, Rodila R, Ji QC, El-Shourbagy TA. Rapid Commun. Mass Spectrom. 2006; 20: 3456.
23. Zhang J, Reimer TM, Alexander NE, Ji QC, El-Shourbagy TA. Rapid Commun. Mass Spectrom. 2006; 20: 3427.
24. Ji QC, Zhang J, Rodila R, Watson P, El-Shourbagy TA. Rapid Commun. Mass Spectrom. 2004; 18: 2293.
25. Zhang J, Kim EJ, Ji QC, El-Shourbagy TA. Rapid Commun. Mass Spectrom. 2006; 20: 3755.
26. Ji QC, Rodila R, Gage EM, El-Shourbagy TA. Anal. Chem. 2003; 75: 7008.
27. Food and Drug Administration of the United States, Guidance for Industry-Bioanalytical Method Validation, US Department of Health and Human Services, Center for Drug Evaluation and Research (CDER), Center for Veterinary Medicine (CVM), May, 2001; Available: http://www.fda.gov/cder/guidance/index.htm